THE US Food and Drug Administration has approved Spinraza (nusineren), the first drug approved to treat children and adults with spinal muscular atrophy (SMA) - a rare and often fatal genetic disease.
Spinraza is administered as a lumbar injection - see fda.gov.
MODELLING commissioned by the Pharmacy Guild of Australia suggests that the goals outlined in its recently released 10-year vision, Towards 2035 (PD 06 Aug), could amount to $5.1 billion in healthcare savings if realised.
TERRYWHITE Chemmart is travelling around the country with its annual Leaders’ Academy, bringing two days of hands-on learning to pharmacy leaders in every state this month.
CHEMIST Warehouse has raised $1.27 million to support the Gotcha4Life Foundation as part of its 2025 Men’s Health Campaign, a national initiative to promote mental fitness and work towards reducing suicide rates in Australia.
Notifications
